Meeting NewsPerspective

Single-agent, targeted therapies induce negligible response among smokers with NSCLC

September 19, 2019
BARCELONA — Targeted therapies for non-small cell lung cancer demonstrated potential benefit in additional molecular stratifications of the…
In the Journals

Maribavir shows promise against CMV in transplant recipients

September 18, 2019
Twice-daily maribavir demonstrated similar efficacy as valganciclovir in clearing cytomegalovirus viremia in hematopoietic-cell or solid-organ…
Feature

Seattle Cancer Care Alliance opens its doors to share its cellular therapy experience

September 18, 2019
The Seattle Cancer Care Alliance, the clinical care partner of the Fred Hutchinson Cancer Research Center, has been at the forefront of cellular…
Feature

AACR Cancer Progress Report: Past federal investments in NIH spurring breakthroughs in care

September 18, 2019
The American Association for Cancer Research today released its annual Cancer Progress Report, which reflects how prior investment in the NIH is…
Meeting NewsPerspective

High-dose radiation effective in oligometastatic prostate cancer

September 18, 2019
Stereotactic ablative radiation appeared to be an effective and safe treatment for men with oligometastatic prostate cancer, with significant…
FDA News

FDA expands Erleada approval for prostate cancer

September 18, 2019
The FDA expanded the approval of apalutamide to include treatment of men with metastatic castration-sensitive prostate cancer. Apalutamide (Erleada…
Meeting NewsPerspective

Neoadjuvant chemoimmunotherapy induces high rate of pathologic response in lung cancer subset

September 18, 2019
BARCELONA — Neoadjuvant chemoimmunotherapy with nivolumab induced complete pathologic response at an unprecedented rate among patients with…
Meeting News

Induction radiation therapy before CAR-T reduces treatment-related toxicities

September 17, 2019
Patients who received radiation therapy before chimeric antigen receptor T-cell therapy for relapsed or refractory non-Hodgkin lymphoma were less…
Meeting News

FDA announces international collaboration, approves pembrolizumab plus lenvatinib for endometrial cancer

September 17, 2019
The FDA, in conjunction with decisions by regulatory agencies in Australia and Canada, granted accelerated approval to pembrolizumab in combination…
Meeting NewsPerspective

Radiation improves outcomes with pembrolizumab for metastatic lung cancer

September 17, 2019
The addition of stereotactic body radiotherapy after progression on pembrolizumab prolonged PFS among patients with metastatic non-small cell lung…

Fred Hutchinson Cancer Research Center director to step down

September 17, 2019
D. Gary Gilliland, MD, PhD, president and director of Fred Hutchinson Cancer Research Center, announced today that he will step down next…
In the Journals

Breast cancer screening for high-risk men may detect disease early, improve survival

September 17, 2019
Men at high risk for breast cancer may benefit from screening for the disease, according to results of a retrospective study published in…
Meeting NewsPerspective

Low PSA levels predict lack of benefit from long-term hormone therapy after prostate surgery

September 16, 2019
Long-term antiandrogen therapy did not improve OS when administered during early salvage radiation therapy among patients with recurrent prostate…

Combination prolongs PFS in relapsed or refractory myeloma

September 16, 2019
The addition of daratumumab to carfilzomib and dexamethasone extended PFS for patients with relapsed or refractory multiple myeloma, according to…
FDA News

FDA grants priority review to enfortumab vedotin for certain patients with urothelial cancer

September 16, 2019
The FDA granted priority review to enfortumab vedotin for treatment of certain patients with locally advanced or metastatic urothelial cancer. The…
Trend Watch

Penn, Novartis end groundbreaking CAR-T relationship with new, more focused collaboration

September 16, 2019
The 7-year research and development alliance between Novartis and the University of Pennsylvania has concluded, with both organizations entering into…
Orthopedics Today Grand Rounds

A 75-year-old woman with constitutional symptoms, precipitous functional decline

Orthopedics Today, September 2019
Bayard C. Carlson, MD; Douglas W. Bartels, MD; Joshua D. Johnson, MD; Peter S. Rose, MD
A 75-year-old woman with a medical history significant for obesity, diabetes mellitus type 2 and coronary artery disease presented with a 6-month…
In the Journals

Flu vaccination shows modest efficacy among patients with cancer

September 16, 2019
Patients with cancer and cancer survivors should receive seasonal influenza vaccination, although vaccination appeared somewhat less effective for…
Meeting News

Memorial Sloan Kettering Cancer Center oncologist receives lifetime achievement award

September 15, 2019
Charles Rudin, MD, PhD, received the Paul A. Bunn Jr. Scientific Award from International Association for the Study of Lung Cancer. The award…
Meeting News

UCLA professor honored for contributions to lung cancer prevention

September 14, 2019
Denise Aberle, MD, received International Association for the Study of Lung Cancer’s Joseph W. Cullen Prevention/Early Detection Award. The…